Applications of telomerase research in the fight against cancer

Molecular Medicine Today

Volumn 5, Issue 3, 1999, Pages 114-122

  McKenzie, Katherine E ^a   Umbricht, Christopher B ^b   Sukumar, Saraswati ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; TELOMERASE;

BASE PAIRING; CANCER RESEARCH; CELL DEATH; CELL PROTECTION; DNA DAMAGE; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; REVIEW; TELOMERE; TUMOR CELL CULTURE;

ENZYME ACTIVATION; HUMANS; NEOPLASMS; RESEARCH; TELOMERASE; TELOMERE;

EID: 0033047756     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(98)01429-4     Document Type: Review

References (65)

1. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37:1965;614-636.
2. Blackburn E.H. The telomere and telomerase: nucleic acid-protein complexes acting in a telomere homeostasis system. A review. Biochemistry (Mosc.). 62:1997;1196-1201.
3. Watson J.D. The origin of concatemeric T7 DNA. Nat. New Biol. 239:1972;197-201.
4. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature. 345:1990;458-460.
5. Nugent C.I., Lundblad V. The telomerase reverse transcriptase: components and regulation. Genes Dev. 12:1998;1073-1085.
6. Weng N.P.et al. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol. Rev. 160:1997;43-54.
7. Meyerson M.et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 90:1997;785-795.
8. Blackburn E.et al. The telomere and telomerase: how do they interact? Ciba Found. Symp. 211:1997;2-13.
9. Ulaner G.A., Giudice L.C. Developmental regulation of telomerase activity in human fetal tissues during gestation. Mol. Hum. Reprod. 3:1997;769-773.
10. Kim N.W.et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
11. Meeker A.K., Coffey D.S. Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review. Biochemistry (Mosc.). 62:1997;1323-1331.
12. Shay J.W., Bacchetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer. 33:1997;787-791.
13. Carey L.A.et al. Careful histological confirmation and microdissection reveal telomerase activity in otherwise telomerase-negative breast cancers. Clin. Cancer Res. 4:1998;435-440.
14. Hiyama E. Telomerase activity in human breast tumors. J. Natl. Cancer Inst. 88:1996;116-122.
15. Haugen B.R.et al. Telomerase activity in benign and malignant thyroid tumors. Thyroid. 7:1997;337-342.
16. Kyo S. Application of telomerase assay for the screening of cervical lesions. Cancer Res. 57:1997;1863-1867.
17. Umbricht C.B. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Res. 57:1997;2144-2147.
18. Kavaler E.et al. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer. 82:1998;708-714.
19. Kim N.W., Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25:1997;2595-2597.
20. Yahata N.et al. Telomerase activity in lung cancer cells obtained from bronchial washings. J. Natl. Cancer Inst. 90:1998;684-690.
21. Hirose M.et al. A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol. J. Cancer Res. Clin. Oncol. 123:1997;337-344.
22. Norton J.C., Holt S.E., Wright W.E., Shay J.W. Enhanced detection of human telomerase activity. DNA Cell Biol. 17:1998;217-219.
23. Soder A.I., Going J.J., Kaye S.B., Keith W.N. Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization. Oncogene. 16:1998;979-983.
24. Ulaner G.A.et al. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 58:1998;4168-4172.
25. Kolquist K.A.et al. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat. Genet. 19:1998;182-186.
26. Poremba C. Telomerase activity in human proliferative breast lesions. Int. J. Oncol. 12:1998;641-648.
27. Yashima K. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J. Clin. Pathol. 50:1997;110-117.
28. Yoshida K. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br. J. Cancer. 75:1997;548-553.
29. Taylor R.S.et al. Detection of telomerase activity in malignant and nonmalignant skin conditions. J. Invest. Dermatol. 106:1996;759-765.
30. Murakami J. Telomerase activity in ovarian tumors. Cancer. 80:1997;1085-1092.
31. Brien T.P. Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res. 57:1997;2760-2764.
32. Hu B.T.et al. Telomerase is up-regulated in human germinal center B cells in vivo and can be re-expressed in memory B cells activated in vitro. J. Immunol. 159:1997;1068-1071.
33. Brousset P.et al. Telomerase activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease. Blood. 89:1997;26-31.
34. Stetler-Stevenson, M., Medeiros, L.J. and Jaffe, E.S. (1995) Immunophenotypic methods and findings in the diagnosis of lymphoproliferative diseases, in Surgical Pathology of the Lymph Nodes and Related Organs (2nd edn) (Jaffe, E S., ed.), pp. 22-57, W.B. Saunders Co.
35. Avilion A.A.et al. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 56:1996;645-650.
36. Bodnar A.G.et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
37. Takakura M.et al. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 58:1998;1558-1561.
38. Arai T.et al. Application of telomerase activity for screening of primary lung cancer in broncho-alveolar lavage fluid. Oncol. Rep. 5:1998;405-408.
39. Yang C.T., Lee M.H., Lan R.S., Chen J.K. Telomerase activity in pleural effusions: diagnostic significance. J. Clin. Oncol. 16:1998;567-573.
40. Duggan B.D.et al. Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination. J. Natl. Cancer Inst. 90:1998;238-242.
41. Suehara N.et al. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. Clin. Cancer Res. 3:1997;2479-2483.
42. Califano J.et al. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res. 56:1996;5720-5722.
43. Sugino T.et al. Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates. Int. J. Cancer. 69:1996;301-306.
44. Lin Y.et al. Detection of telomerase activity in prostate needle-biopsy samples. Prostate. 36:1998;121-128.
45. Nakashio R.et al. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int. J. Cancer. 74:1997;141-147.
46. Yoshida K.et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer. 79:1997;362-369.
47. Kleinschmidt-DeMasters B.K.et al. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astro-cytomas but shows correlation with Mib-1 labelling. J. Clin. Pathol. 51:1998;284-293.
48. Umbricht C.B.et al. Telomerase activity in ductal carcinoma-in-situ and invasive breast cancer. Oncogene. . (in press).
49. Zhang W., Kapusta L.R., Slingerland J.M., Klotz L.H. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium. Cancer Res. 58:1998;619-621.
50. Nawaz S.et al. Telomerase expression in human breast cancer with and without lymph node metastases. Am. J. Clin. Pathol. 107:1997;542-547.
51. Clark G.M.et al. Telomerase activity and survival of patients with node-positive breast cancer. J. Natl. Cancer Inst. 89:1997;1874-1881.
52. Burger A.M., Double J.A., Newell D.R. Inhibition of telomerase activity by cisplatin in human testicular cancer cells. Eur. J. Cancer. 33:1997;638-644.
53. Kondo Y.et al. Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene. 16:1998;2243-2248.
54. Melana S.M., Holland J.F., Pogo B.G. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3′-azido-3′-deoxythymidine. Clin. Cancer Res. 4:1998;693-696.
55. Gomez D.E., Tejera A.M., Olivero O.A. Irreversible telomere shortening by 3′-azido-2′,3′-dideoxythymidine (AZT) treatment. Biochem. Biophys. Res. Commun. 246:1998;107-110.
56. Sun D.et al. Inhibition of human telomerase by a G-quadruplex-interactive compound. J. Med. Chem. 40:1997;2113-2116.
57. Brown B.A. II et al. Isolation and characterization of a monoclonal anti-quadruplex Dna antibody from autoimmune 'viable motheaten' mice. Biochemistry. 37:1998;16325-16337.
58. Pitts A.E., Corey D.R. Inhibition of human telomerase by 2′-O-methyl-RNA. Proc. Natl. Acad. Sci. U. S. A. 95:1998;11549-11554.
59. Broccoli D., Smogorzewska A., Chong L., de Lange T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat. Genet. 17:1997;231-235.
60. Smith S., Giriat I., Schmitt A., de Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science. 282:1998;1484-1487.
61. Horikawa I., Oshimura M., Barrett J.C. Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol. Carcinog. 22:1998;65-72.
62. Landberg G.et al. Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Res. 57:1997;549-554.
63. Nugent C.I.et al. Telomere maintenance is dependent on activities required for end repair of double-strand breaks. Curr. Biol. 8:1998;657-660.
64. Biessmann H., Mason J.M. Telomere maintenance without telomerase. Chromosoma. 106:1997;63-69.
65. Bryan T.M.et al. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3:1997;1271-1274.